Clinical Trials Directory

Trials / Completed

CompletedNCT05427604

To Evaluate the Effects of Omega 3 Fatty Acids in the Context of Cancer Prevention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Previous studies have demonstrated, in an in vitro micro-tumour model (the spheroid) and in a mouse model, that long-chain omega-3 fatty acids, in particular docosahexaenoic acid (DHA), can inhibit tumour development. Therefore, the aim of this study was to collect DHA-enriched human serum, following ingestion of a DHA-enriched oil, in order to assess its effect on tumour development in vitro. Blood enriched in fatty acids not containing DHA will be used as a control condition, obtained after ingestion of olive oil. This study is an important step to determine the interest of DHA supplementation as a new approach to prevent tumour development, and/or as an adjuvant to cancer treatments.

Detailed description

The objective of this study is to collect DHA-enriched human serum in order to test it on the in vitro tumour model, spheroids. The results will be compared with human serum enriched in fatty acids (saturated, monounsaturated and polyunsaturated) but not in DHA. To do this, the study will be divided into 4 steps 1. determination of the time when a maximum concentration of fatty acids is observed in the serum after ingestion of olive oil (the control condition) 2. blood sampling at baseline (fasting) and at Tmax after olive oil ingestion 3. determination of the time when a maximum concentration of fatty acids is observed in the serum after ingestion of DHA-enriched oil (the test condition) 4. blood sampling at baseline (fasting) and at Tmax after ingestion of DHA-enriched oil.

Conditions

Interventions

TypeNameDescription
OTHEROlive oilingestion of olive oil (3g) and blood measurement at baseline, after 1h, 2h, 3h, 4h, 5h, 6h
OTHEROlive Oilingestion of olive oil (3g) and blood sampling at the fatty acids pic concentration (for in vitro study)
OTHERDHA oilingestion of DHA oil (3g) and blood measurement at baseline, after 1h, 2h, 3h, 4h, 5h, 6h
OTHERDHA oilingestion of DHA oil (3g) and blood sampling at the fatty acids pic concentration (for in vitro study)

Timeline

Start date
2021-02-23
Primary completion
2021-06-21
Completion
2021-06-21
First posted
2022-06-22
Last updated
2022-06-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05427604. Inclusion in this directory is not an endorsement.

To Evaluate the Effects of Omega 3 Fatty Acids in the Context of Cancer Prevention (NCT05427604) · Clinical Trials Directory